Cargando…
Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits
The ability to detect and monitor amyloid deposition in the brain using non-invasive imaging techniques provides valuable insights into the early diagnosis and progression of Alzheimer’s disease and helps to evaluate the efficacy of potential treatments. Magnetic resonance imaging (MRI) is a widely...
Autores principales: | Nikiforova, Alena, Sedov, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342860/ https://www.ncbi.nlm.nih.gov/pubmed/37446329 http://dx.doi.org/10.3390/ijms241311152 |
Ejemplares similares
-
Binding Constants of Substituted Benzoic Acids with Bovine Serum Albumin
por: Khaibrakhmanova, Diliara, et al.
Publicado: (2020) -
Molecular Mechanisms of Inhibition of Protein Amyloid Fibril Formation: Evidence and Perspectives Based on Kinetic Models
por: Sedov, Igor, et al.
Publicado: (2022) -
Theranostics and contrast agents for magnetic resonance imaging
por: Jeong, Yohan, et al.
Publicado: (2018) -
Use of contrast agents in oncological imaging: magnetic resonance imaging
por: Morana, Giovanni, et al.
Publicado: (2013) -
Contrast Agents of Magnetic Resonance Imaging and Future Perspective
por: Lv, Jie, et al.
Publicado: (2023)